We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $19.8B
1-Year Est. Return 31.12%
This Fund
S&P 500
This Quarter Est. Return
+10.62%
1 Year Est. Return
+31.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.4B
AUM Growth
+$5.27B
Cap. Flow
+$4.41B
Cap. Flow %
33.05%
Top 10 Hldgs %
40.06%
Holding
653
New
37
Increased
548
Reduced
43
Closed
25

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$325M
2
MSFT icon
Microsoft
MSFT
+$284M
3
AAPL icon
Apple
AAPL
+$259M
4
AMZN icon
Amazon
AMZN
+$196M
5
AVGO icon
Broadcom
AVGO
+$156M

Top Sells

Rank Stock Value
1
ANSS
Ansys
ANSS
+$7.26M
2
APG icon
APi Group
APG
+$4.66M
3
HES
Hess
HES
+$3.46M
4
HRI icon
Herc Holdings
HRI
+$2.37M
5
BEP icon
Brookfield Renewable
BEP
+$1.85M

Sector Composition

Rank Sector Weight
1 Technology 39.45%
2 Communication Services 11.82%
3 Consumer Discretionary 10.45%
4 Healthcare 7.02%
5 Financials 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REPL icon
626
Replimune Group
REPL
$1.18B
$180K ﹤0.01%
42,966
+2,060
+5% +$13.2K
DAWN
627
DELISTED
Day One Biopharmaceuticals
DAWN
$138K ﹤0.01%
19,542
-104,768
-84% -$721K
DBRG icon
628
DigitalBridge
DBRG
$2.95B
$117K ﹤0.01%
+10,040
New +$112K
ACAD icon
629
Acadia Pharmaceuticals
ACAD
$5.09B
-10,596
Closed -$229K
ANSS
630
DELISTED
Ansys
ANSS
-20,680
Closed -$7.26M
ARVN icon
631
Arvinas
ARVN
$587M
-72,114
Closed -$531K
AXSM icon
632
Axsome Therapeutics
AXSM
$11.4B
-2,327
Closed -$243K
BEP icon
633
Brookfield Renewable
BEP
$10.2B
-72,683
Closed -$1.85M
CGEM icon
634
Cullinan Oncology
CGEM
$1.26B
-42,692
Closed -$321K
CNI icon
635
Canadian National Railway
CNI
$76B
-11,357
Closed -$1.18M
CPRX
636
DELISTED
Catalyst Pharmaceutical
CPRX
-11,352
Closed -$246K
CZR icon
637
Caesars Entertainment
CZR
$6.09B
-17,034
Closed -$484K
DNLI icon
638
Denali Therapeutics
DNLI
$4.02B
-15,174
Closed -$212K
ENPH icon
639
Enphase Energy
ENPH
$5.53B
-8,922
Closed -$354K
GFL icon
640
GFL Environmental
GFL
$14.9B
-30,106
Closed -$1.52M
GPCR icon
641
Structure Therapeutics
GPCR
$3.74B
-22,880
Closed -$475K
HES
642
DELISTED
Hess
HES
-24,960
Closed -$3.46M
JNPR
643
DELISTED
Juniper Networks
JNPR
-25,399
Closed -$1.01M
MREO
644
Mereo BioPharma
MREO
$56.6M
-102,583
Closed -$278K
PARA
645
DELISTED
Paramount Global Class B
PARA
-41,909
Closed -$541K
RACE icon
646
Ferrari
RACE
$72.1B
-469
Closed -$230K
RCKT icon
647
Rocket Pharmaceuticals
RCKT
$382M
-32,030
Closed -$78.5K
TALK icon
648
Talkspace
TALK
$867M
-27,834
Closed -$77.4K
TEVA icon
649
Teva Pharmaceuticals
TEVA
$42.5B
-28,861
Closed -$484K
VKTX icon
650
Viking Therapeutics
VKTX
$3.98B
-19,755
Closed -$524K

Similar funds

NEOS Investment Management's Q3 2025 Portfolio in Review

As of Q3 2025, NEOS Investment Management held 653 positions worth $13.4B, up 65% from $8.08B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

NEOS Investment Management deployed $4.41B of net new capital in Q3 2025, opening 37 new positions and adding to 548 existing holdings. Its largest new stake was Thomson Reuters: 134,228 shares worth $21.2M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 38% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was APi Group, an estimated $4.66M trimmed.

  • NEOS Investment Management's largest Q3 2025 buy was Thomson Reuters: 134,228 shares worth $21.2M.
  • NEOS Investment Management added most to NVIDIA in Q3 2025, an estimated $325M increase.
  • NEOS Investment Management's biggest Q3 2025 reduction was APi Group, cutting an estimated $4.66M.
  • NEOS Investment Management fully exited Ansys in Q3 2025, selling an estimated $7.26M.
  • NEOS Investment Management's ten largest holdings make up 40% of its $13.4B portfolio in Q3 2025.
  • NEOS Investment Management opened 37 new positions and closed 25 in Q3 2025.
  • NEOS Investment Management's portfolio value rose 65% quarter-over-quarter to $13.4B.

Based on NEOS Investment Management's 13F filing for Q3 2025, filed 7 Nov 2025.